Senior Manager, Financial Reporting jobs in United States
cer-icon
Apply on Employer Site
company-logo

Madrigal Pharmaceuticals · 1 month ago

Senior Manager, Financial Reporting

Madrigal Pharmaceuticals is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The Senior Manager, Financial Reporting will play a crucial role in the financial statement close and consolidations processes, ensuring the accuracy, timeliness, and integrity of consolidated financial results and compliance with applicable accounting standards.

BiopharmaBiotechnologyMedical DevicePharmaceutical

Responsibilities

Prepare reporting packages for financial statements and internal reporting
Assist in the preparation and filing of quarterly and annual reports on Forms 10-Q and 10-K, respectively, in accordance with SEC regulations
Prepare the consolidated cash flow statement
Lead the monthly and quarterly consolidation tasks of Madrigal’s 10+ legal entities (multi-currency), including preparing and managing top-side journal entries
Oversee global intercompany eliminations entries
Manage global chart of accounts and financial statement line-item mappings in DataRails
Ensure appropriate integration and connection of DataRails with Madrigal’s ERP systems
Continuously enhance the close and financial reporting processes to improve efficiency, accuracy, and internal controls
Contribute to the financial close, as needed, as reviewer of reconciliations or preparer of memos / workpapers for complex accounting transactions
Stay current on new accounting standards and SEC rules and regulations, implementing changes to reporting processes as necessary
Assist with the implementation of new accounting standards and miscellaneous accounting-related projects (e.g. business development and M&A projects, etc.)
Coordinate with internal and external auditors
Coach other team members on accounting matters and provide exposure to staff on areas within SEC reporting to expand the team’s skillsets
All activities of this position will be performed in conformance with our established policies as well as US GAAP, SOX, and any other applicable regulatory requirements

Qualification

CPA designationSEC reporting experienceUS GAAP knowledgeNetSuite experienceWorkiva platform experienceCPM tools experienceAnalytical skillsPharmaceutical industry experienceCommunication skillsAttention to detailProblem-solving skillsTeam collaboration

Required

Bachelor's degree in accounting or related field
7+ years of experience in public accounting and/or SEC reporting and consolidations in a public company
Strong understanding of US GAAP, SEC regulations, and financial reporting requirements
Excellent analytical and problem-solving skills
Effective communication and collaboration skills with the ability to interact with cross-functional teams and external stakeholders
Ability to provide clear explanations of accounting matters to team members of all levels
Self-motivated individual who can proactively identify potential challenges and take the initiative to address them
Strong attention to detail
Ability to work in a fast-paced environment, including the ability to successfully manage and adapt to shifting priorities, competing demands, and unexpected changes

Preferred

CPA designation strongly preferred
Mix of Big 4 and industry experience preferred
Experience with NetSuite and SEC reporting platform Workiva a plus
Experience with CPM tools (e.g. OneStream, DataRails, Hyperion)
Experience in the pharmaceutical, biotechnology, or life sciences industries is a plus

Benefits

Flexible paid time off
Medical
Dental
Vision and life/disability insurance
401(k) offerings (i.e., traditional, Roth, and employer match)
Supplemental life insurance
Legal services
Mental health benefits through our Employee Assistance Program for employees and their family

Company

Madrigal Pharmaceuticals

twittertwittertwitter
company-logo
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Funding

Current Stage
Public Company
Total Funding
$1.94B
Key Investors
Blue OwlHercules Capital
2025-07-22Post Ipo Debt· $350M
2024-03-18Post Ipo Equity· $690M
2023-09-28Post Ipo Equity· $500M

Leadership Team

leader-logo
Mardi C. Dier
Chief Financial Officer
linkedin
leader-logo
Carole Huntsman
Chief Commercial Officer (CCO)
linkedin
Company data provided by crunchbase